FDA Inspection 1103282 — CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd.
The FDA completed an inspection of CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. on Sep 4, 2019 in Shijiazhuang. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 4, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shijiazhuang (China)